ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Protokinetix Inc (PK)

Protokinetix Inc (PK) (PKTX)

0.0104
0.00
(0.00%)
Cerrado 27 Marzo 2:00PM

Su centro para precios en tiempo real, ideas y debates en vivo

PKTX Noticias

Solo noticias oficiales

PKTX Discussion

Ver más
disgusted investor disgusted investor 6 días hace
only if they didn't own any before that. If I bought at .008 and sold at .015, the stock I bought years ago at .02 or whatever gets sold for a loss.
👍️0
GJ1212 GJ1212 7 días hace
Looks like whoever bought a boat load at 0.008 ..... sold last week at 0.015 for a nice, almost 💯, profit !!!
👍 1
disgusted investor disgusted investor 1 semana hace
unfortunately, so much for that outlook
👍️0
disgusted investor disgusted investor 2 semanas hace
kind of a disappointing week for this stock. There was a ton of volume.
👍 1
disgusted investor disgusted investor 2 semanas hace
I recall thinking that was misleading, especially the headline. The stem cells restored the vision . The AAGP help the stem cells survive.
👍 1
SPORT19 SPORT19 2 semanas hace
https://www.protokinetix.com/protokinetix-aagp-restores-vision-in-blind-test-subjects/
👍 1
disgusted investor disgusted investor 2 semanas hace
I don't recall it curing blindness in mice, but it helped the cells implanted in the eyes thrive instead of disappointing the researchers
👍️0
SPORT19 SPORT19 2 semanas hace
Huge potential...already clinically tested and safe on humans...cured blindness in mice...
👍️0
Past and present Past and present 2 semanas hace
***PKTX..
Stem Cell Therapy Reverses Diabetes..***

According to a new study published in Science Advances, researchers have developed a novel cell transplantation technique that successfully reversed type 1 diabetes in mice, using human islets vascularized with adaptable endothelial cells for functional subcutaneous engraftment.

Breakthrough in Islet Transplantation
The innovative technique employs human reprogrammed vascular endothelial cells (R-VECs) to functionally vascularize pancreatic islets, addressing a major challenge in islet transplantation therapy1. This approach enables:

In vitro functional vascularization of islets with responsive glucose-stimulated insulin secretion

Successful reversal of hyperglycemia in diabetic mice through subcutaneous transplantation

High levels of human insulin in recipient serum, with hyperglycemia returning upon graft removal

R-VECs, engineered by transiently expressing the vascular-specific transcription factor ETV2, demonstrate remarkable adaptability by self-assembling into perfusable vascular networks and acquiring islet endothelial cell-specific characteristics when cocultured with human islets12. This breakthrough represents a significant step towards improved islet transplantation therapy, potentially offering a path to long-term insulin independence for type 1 diabetes patients34.

ncbi.nlm.nih.gov favicon
science.org favicon
pubmed.ncbi.nlm.nih.gov favicon
4 sources
Role of R-VECs in Vascularization
Microenvironmental determinants of endothelial cell ...
Reprogrammed vascular endothelial cells (R-VECs) play a crucial role in enhancing islet transplantation outcomes by providing robust vascularization. Their unique properties and adaptability make them particularly effective for supporting islet survival and function:

R-VECs form extensive vascular networks that arborize and penetrate islets, mimicking native pancreatic vasculature12

When co-cultured with islets, R-VECs acquire islet endothelial cell-specific characteristics, demonstrating remarkable adaptability34

R-VEC-formed blood vessels have larger diameters (13.5 ± 7.5 µm) compared to native human islet capillaries (6.8 ± 2.1 µm), potentially improving blood flow1

Cotransplanted R-VECs contribute substantially more to islet vascularization than host endothelial cells in subcutaneous transplants1

The vascular network formed by R-VECs successfully anastomoses with host circulation, ensuring long-term graft survival31

This advanced vascularization technique addresses a major challenge in islet transplantation, potentially improving graft survival and function while enabling transplantation in more accessible sites like the subcutaneous space.

pubmed.ncbi.nlm.nih.gov favicon
ncbi.nlm.nih.gov favicon
4 sources
Subcutaneous Transplantation Success
Subcutaneous transplantation of vascularized islets marks a significant advancement in type 1 diabetes treatment. This site offers several advantages, including a large surface area, easy accessibility for transplantation and monitoring, and potential graft retrieval if necessary1. Previous attempts at subcutaneous islet transplantation had failed due to insufficient vascularization, but the use of R-VECs overcomes this challenge by forming blood vessels that arborize and vascularize the islets, effectively connecting with the host circulation23.

Transplanted R-VECs form functional blood vessels that support islet survival

Subcutaneous site allows for non-invasive monitoring and potential graft removal

Successful reversal of hyperglycemia in diabetic mice demonstrates the technique's efficacy12

ncbi.nlm.nih.gov favicon
science.org favicon
3 sources
Implications for Type 1 Diabetes
This innovative approach addresses several key challenges in islet transplantation therapy, including the scarcity of donor organs and islet loss due to disconnection from extracellular matrix and vasculature during isolation1. By enabling effective vascularization, the technique potentially reduces inflammatory and rejection reactions that compromise islet survival1. Importantly, this method may pave the way for transplantation without the need for lifelong immunosuppression, a significant drawback of conventional approaches2. The success of this technique in animal models represents a promising step towards translating this therapy to human patients, offering hope for a more effective and durable treatment for type 1 diabetes34.
👍 1
Past and present Past and present 2 semanas hace
https://www.perplexity.ai/page/stem-cell-therapy-reverses-dia-clGsnmywR4ugK
👍️0
BurgerKing82 BurgerKing82 2 semanas hace
This one may have potential....What is the OS?
👍️0
HyperPirate75 HyperPirate75 2 semanas hace
Yeah but still very interesting to see a successful therapy using islet transplant to cure diabetes 1, which is making headlines.. And it's making headlines while it was conducted on mices, PKTX study is on human beings, much more impactful
👍 2
disgusted investor disgusted investor 2 semanas hace
they don't mention anything obvious specifically about AAGP or any companies. though. Could be all sorts of other research involved in islets transplantation.
👍️0
HyperPirate75 HyperPirate75 2 semanas hace
Look at this guys, this is our time to shine !!!
👍 1
Past and present Past and present 3 semanas hace
***PKTX.. Dearest Ole Sun.. Have a Good Day and go back to sleep.. :+)
👍️ 1
sunspotter sunspotter 3 semanas hace
With volume like today’s so far, how could it fail?
👍️0
disgusted investor disgusted investor 3 semanas hace
it's got to reach .05 first : )
👍️0
GJ1212 GJ1212 3 semanas hace
Company gonna get bought out ...... at $0.05 per share.
👍 1 🚀 1
SPORT19 SPORT19 3 semanas hace
.0142 with nice bid support!

NEWS COMING!!!!!
👍️0
disgusted investor disgusted investor 3 semanas hace
your attitude seems to have changed
👍️0
SPORT19 SPORT19 3 semanas hace
News coming!

Close at or above.015
👍️0
disgusted investor disgusted investor 4 semanas hace
surprised there isn't more insider buying if something is going on that's positive
👍 1
disgusted investor disgusted investor 4 semanas hace
see what happens next week.
👍️0
SPORT19 SPORT19 4 semanas hace
News coming????
Watch for a jump in PPS


👍️0
disgusted investor disgusted investor 4 semanas hace
nice volume and a tiny increase in price
👍️0
disgusted investor disgusted investor 4 semanas hace
no movement in price, but nice volume
👍️0
scoobey-do scoobey-do 1 mes hace
HyperPirate75, I see you are new to Investor's hub and to PhotoKinetix's board. Welcome to the IHub board. I look forward to your thoughts regarding PhotoKinetix's Islet transplant test.
👍️ 1
HyperPirate75 HyperPirate75 1 mes hace
Interesting opinion but i think you are wrong, this stock has been manipulated and accumulated for years, if they do end up posting positive data for a study about diabetes 1, the stock will go up. Islet transplant is a very new method to treat diabete 1 and Alberta uni is at the forefront of this new method, if PKTX enables safer and more efficient islet transplant, it will be a big deal
👍️0
GJ1212 GJ1212 1 mes hace
The share price will never move up. If it ever gets to five cents ..... those who bought millions and millions of shares at one cent or less will dump them all. Then the PPS will collapse again. The only true way for everyone to get something out of this stock is for there to be a negotiated total buyout. (only my opinion)
👍 1
disgusted investor disgusted investor 1 mes hace
2021 was the last time this stock crossed through both the 50 and 200 day moving averages.
👍️0
disgusted investor disgusted investor 1 mes hace
I am not selling. When people stop selling, it might move up
👍️0
SPORT19 SPORT19 1 mes hace
Big volume today....but as you see the PPS doesn't move....
👍️0
Past and present Past and present 1 mes hace
***PKTX..If you call almost a million trades low.. :+O
👍 1
disgusted investor disgusted investor 1 mes hace
Wow. Very little volume again today
👍️0
Past and present Past and present 1 mes hace
***PKTX.. Whatever you say.. Ole Wise One.. :+)
👍️ 1
sunspotter sunspotter 1 mes hace
I'm sorry for your loss.
👍️0
disgusted investor disgusted investor 1 mes hace
shmp has just about set itself on fire. They had a fire years ago and are worth less now than after the ashes were swept up
👍️0
Past and present Past and present 1 mes hace
***PKTX.. Dear "disgusted investor"...I hope your day is going well.. I have a question for you, why do you say "One thing about PKTX" on this MB, But say something totally opposite on another MB..(Natural Shrimp Inc.(SHMP).. About PKTX..???

***(Your Quote).."this stock is worse than my PKTX AAGP stock Protokinetix"..

***disgusted investor.. Don't worry about your comment on that MB(Natural Shrimp Inc.(SHMP)..At least we "Now" know what you are here on PKTX for..

***Have a great day, tell your buddy SPORT19 hello.. :+)
👍️ 1
disgusted investor disgusted investor 1 mes hace
plenty of volume
👍️0
disgusted investor disgusted investor 1 mes hace
to put around my tomato plants?
😜 1
SPORT19 SPORT19 1 mes hace
Why?
👍 1
disgusted investor disgusted investor 1 mes hace
bought some more shares
👍️0
disgusted investor disgusted investor 2 meses hace
I know I am not selling.
👍️0
disgusted investor disgusted investor 2 meses hace
another nice day of volume 310000 2/5/25
👍️0
HyperPirate75 HyperPirate75 2 meses hace
2 more months not 3 mb
👍️0
HyperPirate75 HyperPirate75 2 meses hace
Lmao they changed the date of completion again, this time we get a precise date the 25th of march, let's see on the 25th if they put 3 more months to the clock
👍 1
SPORT19 SPORT19 2 meses hace
This thing is a dog....awful 
👍️0
SPORT19 SPORT19 2 meses hace
If there was anything going on the ask would be swallowed up....
This is how they set up the dump....
👍 2
disgusted investor disgusted investor 2 meses hace
something must be up with the clinical results to have this trade 400,000 shares to start the day 1/28/25
🤢 1
disgusted investor disgusted investor 2 meses hace
got a link to what you are looking at?
👍️0